| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF01974981 |
| P698 | PubMed publication ID | 1870943 |
| P2093 | author name string | Lafaix C | |
| Vincent-Ballereau FN | |||
| Patey ON | |||
| P2860 | cites work | Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes | Q28360287 |
| Azole antifungal agents: emphasis on new triazoles | Q35287663 | ||
| Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis | Q35295703 | ||
| Pharmacokinetics and tissue penetration of fluconazole in rabbits | Q35325949 | ||
| Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis | Q35535337 | ||
| Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans | Q35572405 | ||
| Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice | Q35648045 | ||
| Comparison of the in vitro and in vivo activity of the bis-triazole derivative UK 49,858 with that of amphotericin B against Histoplasma capsulatum | Q35649804 | ||
| Fluconazole in the treatment of candidal prosthetic valve endocarditis | Q35702569 | ||
| Susceptibility of Candida albicans and other yeasts to fluconazole: relation between in vitro and in vivo studies | Q37918353 | ||
| Pharmacokinetics and tissue penetration of fluconazole in humans | Q37918375 | ||
| Fluconazole, a new antifungal agent | Q37943116 | ||
| Secondary mycosis in surgery: treatment with fluconazole | Q38269774 | ||
| Fluconazole in the treatment of fungal infections associated with AIDS. | Q38274828 | ||
| Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study | Q39167869 | ||
| Treatment of systemic fungal infections: recent progress and current problems | Q39277897 | ||
| Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice | Q39814888 | ||
| Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans | Q39817645 | ||
| Fluconazole and testosterone: in vivo and in vitro studies. | Q39818132 | ||
| Comparative activities of UK-49,858 and amphotericin B against Blastomyces dermatitidis infections in mice | Q39850792 | ||
| Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits | Q39851052 | ||
| Improved method for azole antifungal susceptibility testing | Q40195698 | ||
| A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis | Q41644134 | ||
| Fluconazole and phenytoin: a predictable interaction | Q41877924 | ||
| Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial | Q43632037 | ||
| Fluconazole-induced jaundice | Q43702524 | ||
| Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro | Q43889167 | ||
| Treatment of two cases of cryptococcal meningitis with fluconazole | Q43913710 | ||
| Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice | Q44477824 | ||
| Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): successful treatment with fluconazole after failure of amphotericin B. | Q44551000 | ||
| Interaction of fluconazole and cyclosporine | Q44661676 | ||
| A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections | Q46815200 | ||
| Intraventricular therapy of cryptococcal meningitis via a subcutaneous reservoir | Q48325991 | ||
| Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment | Q48379750 | ||
| Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. | Q54121244 | ||
| Itraconazole therapy for cryptococcal meningitis and cryptococcosis. | Q54344117 | ||
| INTERACTION OF FLUCONAZOLE WITH CYCLOSPORIN | Q57651587 | ||
| Cryptococcal meningitis in patients with AIDS | Q68128522 | ||
| Drug interactions with fluconazole | Q68764002 | ||
| Cryptococcal infections in patients with acquired immune deficiency syndrome | Q68887768 | ||
| Single-dose therapy for oral candidiasis with fluconazole in HIV-infected adults: a pilot study | Q69334948 | ||
| A comparison of single-dose oral fluconazole with 3-day intravaginal clotrimazole in the treatment of vaginal candidiasis. Report of an international multicentre trial | Q69337425 | ||
| Treatment of systemic yeast infection with fluconazole | Q69340779 | ||
| Fluconazole in renal candidosis | Q69367046 | ||
| Fluconazole and candidosis | Q69367422 | ||
| Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS | Q69368341 | ||
| Hypokalaemia in patients with acute myeloid leukaemia after treatment with fluconazole | Q69369158 | ||
| Interaction of fluconazole with cyclosporin | Q69371225 | ||
| Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system | Q69814579 | ||
| Comparison of two azole antifungal drugs, ketoconazole, and fluconazole, as modifiers of rat hepatic monooxygenase activity | Q69815869 | ||
| Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients | Q69829258 | ||
| Fluconazole penetration into cerebrospinal fluid in humans | Q69832022 | ||
| Treatment of vaginal candidiasis with a single oral dose of fluconazole. Multicentre Study Group | Q69835419 | ||
| Treatment of coccidioidal meningitis with fluconazole | Q69838919 | ||
| A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial | Q69849583 | ||
| Fluconazole resistance in Candida glabrata | Q69927092 | ||
| Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits | Q70101291 | ||
| Treatment of cryptococcal meningitis in mice with fluconazole | Q70148103 | ||
| Treatment of murine histoplasmosis with UK 49,858 (fluconazole) | Q70149985 | ||
| Cryptococcal meningitis and fluconazole | Q70173240 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 45-57 | |
| P577 | publication date | 1991-04-01 | |
| P1433 | published in | Pharmaceutisch weekblad. Scientific edition | Q27712605 |
| P1476 | title | Fluconazole. Review and situation among antifungal drugs in the treatment of opportunistic mycoses of human immuno-deficiency virus infections | |
| P478 | volume | 13 |
| Q40260689 | Identification of Fungal Species in Brain Tissue from Alzheimer's Disease by Next-Generation Sequencing |
| Q34233208 | Influence of permeant lipophilicity on permeation across human sclera |
| Q34346510 | The pharmacokinetics of fluconazole after a single intravenous dose in AIDS patients |
Search more.